Dehydro isradipine
CAS: 116169-18-7
Ref. 3D-FD20919
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester4-(4-Benzofurazanyl)-2,6-dimethyl -3,5-pyridinedicarboxylic acid methyl 1-methylethyl esterPN 203-831
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- 4-(4-Benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- Dehydro Isradipine
- Methyl Propan-2-Yl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethylpyridine-3,5-Dicarboxylate
Dehydro isradipine is a high performance liquid chromatography (HPLC) method for the analysis of isradipine. It was developed as an alternative to the standard reversed-phase HPLC method. The HPLC method has been validated and found to be superior in terms of sensitivity, linearity, and capability for quantification. Dehydro isradipine can be analyzed by reversed-phase or liquid chromatography methods. Dehydro isradipine inhibits cytochrome P450 enzymes, which are involved in the metabolism of many drugs, thus affecting their efficacy. This inhibition may lead to adverse drug reactions or reduced therapeutic effect.
Propriedades químicas
Consulta técnica sobre: 3D-FD20919 Dehydro isradipine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.